M4MM

Canopy Growth Powers European Expansion with UK Entry

SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...

Trulieve Earns Its Spot on the S&P Indices

TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...

Canopy Growth Powers European Expansion with UK Entry

SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...

Trulieve Earns Its Spot on the S&P Indices

TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...

GTI Bets on Its Own Stock, Again

CHICAGO – Green Thumb Industries Inc. announced that its board of directors had authorized a $50 million share repurchase program – the company's third consecutive buyback initiative since 2023. Under the new program, Green Thumb ...

Canopy Growth Powers European Expansion with UK Entry

SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...

Trulieve Earns Its Spot on the S&P Indices

TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...

Canopy Growth Powers European Expansion with UK Entry

SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...

Trulieve Earns Its Spot on the S&P Indices

TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...

GTI Bets on Its Own Stock, Again

CHICAGO – Green Thumb Industries Inc. announced that its board of directors had authorized a $50 million share repurchase program – the company's third consecutive buyback initiative since 2023. Under the new program, Green Thumb ...

Vireo Growth Completes M3 Wellness Acquisition

MINNEAPOLIS – Vireo Growth Inc. announced the completion of its acquisition of M3 Wellness, a retail Cannabis dispensary in Hawthorne, NV. Structured as an indirect asset purchase from M3 Wellness, LLC under an agreement signed ...

Public Opinion Fires Up Support for Cannabis in NC

RALEIGH – A large majority of North Carolina adults support legalizing adult-use Cannabis for medical use, and a smaller but clear majority backs recreational legalization as well, according to an Elon University Poll. The survey ...

TerrAscend Closes Acquisition of Aunt Mary’s in NJ

TORONTO – TRENTON – TerrAscend Corp. confirmed it has closed its previously announced transaction with Aunt Mary's Dispensary LLC, a Cannabis retail operation in Hunterdon County, NJ. The deal marks the company's fifth retail location ...

Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute

EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf ...

Definium Achieves Second Positive Phase 3 for GAD

NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and ...

Subscribe To Our Newsletter